Current concepts of the pathogenesis of RSV bronchiolitis

Advances in Experimental Medicine and Biology

Volumn 634, Issue , 2009, Pages 31-40

  Bont, Louis ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RESPIRATORY SYNCYTIAL VIRUS VACCINE;

ADAPTIVE IMMUNITY; ARTICLE; GENETIC RISK; HUMAN; IMMUNOPATHOGENESIS; INFECTION RISK; INNATE IMMUNITY; MORBIDITY; MYELOID DENDRITIC CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VACCINATION; VIRAL BRONCHIOLITIS; VIRUS IMMUNITY; VIRUS PATHOGENESIS; WHEEZING;

RICE STRIPE VIRUS;

EID: 84934436820     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-79838-7_3     Document Type: Article

References (51)

1. Aberle, J. H., Aberle, S. W., Dworzak, M. N., Mandl, C. W., Rebhandl, W., Vollnhofer, G., Kundi, M., and Popow-Kraupp, T. (1999). Reduced Interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am. J. Respir. Crit. Care Med. 160, 1263-1268. (Pubitemid 29487469)
2. Adkins, B., Leclerc, C., and Marshall-Clarke, S. (2004). Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4, 553-564. (Pubitemid 38931770)
3. Awomoyi, A. A., Rallabhandi, P., Pollin, T. I., Lorenz, E., Sztein, M. B., Boukhvalova, M. S., Hemming, V. G., Blanco, J. C., and Vogel, S. N. (2007). Association of TLR4 Polymorphisms with Symptomatic Respiratory Syncytial Virus Infection in High-Risk Infants and Young Children. J. Immunol. 179, 3171-3177.
4. Bendelja, K., Gagro, A., Bace, A., Lokar-Kolbas, R., Krsulovic-Hresic, V., Drazenovic, V., Mlinaric-Galinovic, G., and Rabatic, S. (2000). Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry. Clin. Exp. Immunol. 121, 332-338. (Pubitemid 30659773)
5. Bloemers, B., Furth v, A. M., Weijerman, M., Broers, C., Gemke, R. J. B. J., Strengers, J. L. M., Kimpen, J. L. L., and Bont, L. (2007). Increased incidence of respiratory syncytial virus lower respiratory hospitalisation in children with Down syndrome. Pediatrics. 121(4), e1076-1081.
6. Bont, L., Aalderen, v. W. M. C., and Kimpen, J. L. L. (2000). Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis. Paediatr. Respir. Rev. 1, 221-227.
7. Bont, L., Heijnen, C. J., Kavelaars, A., van Aalderen, W. M., Brus, F., Draaisma, J. M., Pekelharing-Berghuis, M., Diemen-Steenvoorde, R. A., and Kimpen, J. L. (2001). Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J. Infect. Dis. 184, 355-358. (Pubitemid 32662184)
8. Bont, L., Kavelaars, A., Heijnen, C. J., van Vught, A. J., and Kimpen, J. L. (2000b). Monocyte interleukin-12 production is inversely related to duration of respiratory failure in respiratory syncytial virus bronchiolitis. J. Infect. Dis. 181, 1772-1775. (Pubitemid 30387775)
9. Bont, L. and Kimpen, J. L. (2002). Immunological mechanisms of severe respiratory syncytial virus bronchiolitis. Intensive Care Med. 28, 616-621. (Pubitemid 34594594)
10. Cannon, M. J., Openshaw, P. J. M., and Askonas, B. A. (1988). Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168, 1163-1168.
11. Chang, J. and Braciale, T. J. (2002). Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat. Med. 8, 54-60. (Pubitemid 34101729)
12. Choi, E. H., Lee, H. J., Yoo, T., and Chanock, S. J. (2002). A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J. Infect. Dis. 186, 1207-1211. (Pubitemid 35192998)
13. Copenhaver, C. C., Gern, J. E., Li, Z., Shult, P. A., Rosenthal, L. A., Mikus, L. D., Kirk, C. J., Roberg, K. A., Anderson, E. L., Tisler, C. J., DaSilva, D. F., Hiemke, H. J., Gentile, K., Gangnon, R. E., and Lemanske, R. F., Jr. (2004). Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir. Crit Care Med. 170, 175-180. (Pubitemid 38925164)
14. de Graaff, P. M., de Jong, E. C., van Capel, T. M., van Dijk, M. E., Roholl, P. J., Boes, J., Luytjes, W., Kimpen, J. L., and van Bleek, G. M. (2005). Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells. J. Immunol. 175, 5904-5911. (Pubitemid 41508075)
15. Ermers, M. J., Hoebee, B., Hodemaekers, H. M., Kimman, T. G., Kimpen, J. L., and Bont, L. (2007). IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection. J. Allergy Clin. Immunol. 119(5), 1086-1091. (Pubitemid 46654163)
16. Feltes, T. F., Cabalka, A. K., Meissner, H. C., Piazza, F. M., Carlin, D. A., Top, F. H., Jr., Connor, E. M., and Sondheimer, H. M. (2003). Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J. Pediatr. 143, 532-540. (Pubitemid 37352516)
17. Garofalo, R. P., Mei, F., Espejeo, R., Ye, G., Haeberle, H., Baron, S., Ogra, P. L., and Reyes, V. E. (1996). Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class 1 MHC Expression through the induction of IFN-beta and IL-1-alpha. J. Immunol. 157, 2506-2513. (Pubitemid 126450463)
18. Gern, J. E., Brooks, G. D., Meyer, P., Chang, A., Shen, K., Evans, M. D., Tisler, C., Dasilva, D., Roberg, K. A., Mikus, L. D., Rosenthal, L. A., Kirk, C. J., Shult, P. A., Bhattacharya, A., Li, Z., Gangnon, R., and Lemanske, R. F., Jr. (2006). Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. J Allergy Clin. Immunol. 117, 72-78. (Pubitemid 43017142)
19. Goetghebuer, T., Isles, K., Moore, C., Thomson, A., Kwiatkowski, D., and Hull, J. (2004). Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis. Clin. Exp. Allergy 34, 801-803. (Pubitemid 38736797)
20. Graham, B. S., Bunton, L. A., Wright, P. F., and Karzon, D. T. (1991). Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Invest. 88, 1026-1033.
21. Graham, B. S., Johnson, T. R., and Peebles, R. S. (2000). Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology 48, 237-247.
22. Graham, B. S., Perkins, M. D., Wright, P. F., and Karzon, D. T. (1988). Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26, 153-162.
23. Haland, G., Carlsen, K. C., Sandvik, L., Devulapalli, C. S., Munthe-Kaas, M. C., Pettersen, M., and Carlsen, K. H. (2006). Reduced lung function at birth and the risk of asthma at 10 years of age. N. Engl. J. Med. 355, 1682-1689. (Pubitemid 44583958)
24. Hoebee, B., Rietveld, E., Bont, L., Oosten, M., Hodemaekers, H. M., Nagelkerke, N. J., Neijens, H. J., Kimpen, J. L., and Kimman, T. G. (2003). Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. J. Infect. Dis. 187, 2-11. (Pubitemid 36034465)
25. Hull, J., Thomson, A., and Kwiatkowski, D. (2000). Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55, 1023-1027.
26. Inoue, Y., Shimojo, N., Suzuki, Y., Campos Alberto, E. J., Yamaide, A., Suzuki, S., Arima, T., Matsuura, T., Tomiita, M., Aoyagi, M., Hoshioka, A., Honda, A., Hata, A., and Kohno, Y. (2007). CD14-550 C/T, which is relatedto the serum levelof soluble CD14, is associated with the development of respiratory syncytial virus bronchiolitis in the Japanese population. J. Infect. Dis. 195, 1618-1624. (Pubitemid 46799219)
27. Janssen, R., Bont, L., Siezen, C. L., Hodemaekers, H. M., Ermers, M. J., Doornbos, G., van't, S. R., Wijmenga, C., Goeman, J. J., Kimpen, J. L., van Houwelingen, H. C., Kimman, T. G., and Hoebee, B. (2007). Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J. Infect. Dis. 196, 826-834. (Pubitemid 47378931)
28. Johnson, J. E., Gonzales, R. A., Olson, S. J., Wright, P. F., and Graham, B. S. (2007). The histopathology of fatal untreated human respiratory syncytial virus infection. Mod. Pathol. 20, 108-119. (Pubitemid 44967956)
29. Koenig, J. M., Stegner, J. J., Schmeck, A. C., Saxonhouse, M. A., and Kenigsberg, L. E. (2005). Neonatal neutrophils with prolonged survival exhibit enhanced inflammatory and cytotoxic responsiveness. Pediatr. Res. 57, 424-429. (Pubitemid 40293612)
30. Levy, O. (2005). Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists. J. Endotoxin. Res. 11, 113-116. (Pubitemid 40711487)
31. Levy, O. (2007). Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7, 379-390. (Pubitemid 46674489)
32. Levy, O., Coughlin, M., Cronstein, B. N., Roy, R. M., Desai, A., and Wessels, M. R. (2006). The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J. Immunol. 177, 1956-1966. (Pubitemid 44092536)
33. Levy, O., Zarember, K. A., Roy, R. M., Cywes, C., Godowski, P. J., and Wessels, M. R. (2004). Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J. Immunol. 173, 4627-4634. (Pubitemid 39280696)
34. Martinez, F. D., Morgan, W. J., Wright, A. L., Holberg, C. J., and Taussig, L. M. (1988). Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N. Engl. J. Med. 319, 1112-1117.
35. Molloy, E. J., O'Neill, A. J., Grantham, J. J., Sheridan-Pereira, M., Fitzpatrick, J. M., Webb, D. W., and Watson, R. W. (2005). Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function. Pediatr. Res. 57, 806-812. (Pubitemid 40727110)
36. Openshaw, P. J. M. (1995). Immunopathological mechanisms in respiratory syncytial virus disease. Springer Semin Immunopathol. 17, 187-201.
37. Peebles, R. S., Jr. and Graham, B. S. (2005). Pathogenesis of respiratory syncytial virus infection in the murine model. Proc. Am. Thorac. Soc. 2, 110-115. (Pubitemid 41233376)
38. Puthothu, B., Forster, J., Heinzmann, A., and Krueger, M. (2006a). TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease. Dis. Markers 22, 303-308. (Pubitemid 46333629)
39. Puthothu, B., Krueger, M., Forster, J., and Heinzmann, A. (2006b). Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes. J. Infect. Dis. 193, 438-441. (Pubitemid 43122344)
40. Renzi, P. M., Turgeon, J. P., Marcotte, J. E., Drblik, S. P., Berube, D., Gagnon, M. F., and Spier, S. (1999). Reduced interferon-gamma production in infants with bronchiolitis and asthma. Am. J. Respir. Crit Care Med. 159, 1417-1422. (Pubitemid 29227847)
41. Rudd, B. D., Smit, J. J., Flavell, R. A., Alexopoulou, L., Schaller, M. A., Gruber, A., Berlin, A. A., and Lukacs, N. W. (2006). Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J. Immunol. 176, 1937-1942. (Pubitemid 43134339)
42. Schlender, J., Bossert, B., Buchholz, U., and Conzelmann, K. K. (2000). Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J. Virol. 74, 8234-8242. (Pubitemid 30666671)
43. Schlender, J., Hornung, V., Finke, S., Gunthner-Biller, M., Marozin, S., Brzozka, K., Moghim, S., Endres, S., Hartmann, G., and Conzelmann, K. K. (2005). Inhibition of toll-like receptor 7-and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J. Virol. 79, 5507-5515. (Pubitemid 40548219)
44. Simoes, E. A. F. (1999). Respiratory syncytial virus infection. Lancet 354, 847-852. (Pubitemid 29415599)
45. Smyth, R. L. and Openshaw, P. J. (2006). Bronchiolitis. Lancet 368, 312-322. (Pubitemid 44067248)
46. Stein, R. T., Sherill, D., Morgan, W. J., Holberg, C. J., Halonen, M., Taussig, L. M., Wright, A. L., and Martinez, F. D. (1999). Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13. Lancet 354, 541-545. (Pubitemid 29381367)
47. Tal, G., Mandelberg, A., Dalal, I., Cesar, K., Somekh, E., Tal, A., Oron, A., Itskovich, S., Ballin, A., Houri, S., Beigelman, A., Lider, O., Rechavi, G., and Amariglio, N. (2004). Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J. Infect. Dis. 189, 2057-2063. (Pubitemid 38692286)
48. The IMpact-RSV study group (1998). Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102, 531-537.
49. van Woensel, J. and Kimpen, J. (2000). Therapy for respiratory tract infections caused by respiratory syncytial virus. Eur. J. Pediatr. 159, 391-398. (Pubitemid 30329102)
50. Wang, H., Peters, N., and Schwarze, J. (2006). Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J. Immunol. 177, 6263-6270. (Pubitemid 44628844)
51. Yusuf, S., Piedimonte, G., Auais, A., Demmler, G., Krishnan, S., VAN, C. P., Singleton, R., Broor, S., Parveen, S., Avendano, L., Parra, J., Chavez-Bueno, S., DE Sierra, T. M., Simoes, E. A., Shaha, S., and Welliver, R. (2007). The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiol. Infect. 135, 1077-1090. (Pubitemid 47487593)